BRAF V600E MUTATION POSITIVE
Clinical trials for BRAF V600E MUTATION POSITIVE explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E MUTATION POSITIVE trials appear
Sign up with your email to follow new studies for BRAF V600E MUTATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in shrinking aggressive colon tumors before surgery
Disease control Recruiting nowThis study tests whether giving two targeted drugs (encorafenib and cetuximab) before surgery can shrink tumors in people with a specific genetic mutation (BRAF V600E) in localized colon or upper rectal cancer. About 30 participants will receive the drug combination for a short p…
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: PHASE2 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New study tracks Real-World outcomes for BRAF-Mutated colorectal cancer
Knowledge-focused Recruiting nowThis study gathers medical information and biological samples from 400 adults with a specific genetic form of advanced colorectal cancer (BRAFV600E mutation). The goal is to learn how the disease is treated in everyday practice and how long patients live. No new treatments are te…
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: NA • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 10, 2026 14:03 UTC